Alterra Labs secured $12.5 million in seed funding to broaden a medical AI platform that lets developers assess how models handle simulated clinical tasks before deployment in patient care.
Oak HC/FT anchored the financing, with Flare Capital Partners and Company Ventures also taking part. Alterra plans to use the proceeds to grow its assessment and training platform.
Simulated assignments cover care delivery, medical imaging, electronic health records and clinical-trial work. Doctors and scientists build the scenarios and assess the models’ choices. Review findings are turned into further exercises for the models, while expert input can guide developers’ revisions.
The company counts health systems, biotech firms, government entities and drugmakers among the organizations it works with. Alterra has joined the Responsible AI Institute and participates in the TrustX Health working group, which evaluates and validates agentic AI for health care use. Agentic systems can perform parts of a workflow, beyond just answering a prompt.
